These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2072296)

  • 1. Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects.
    Wessinger WD; Owens SM
    J Pharmacol Exp Ther; 1991 Jul; 258(1):207-15. PubMed ID: 2072296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys.
    Slifer BL; Balster RL; Woolverton WL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):399-406. PubMed ID: 6540304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence.
    Spain JW; Klingman GI
    J Pharmacol Exp Ther; 1985 Aug; 234(2):415-24. PubMed ID: 4040569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acute and chronic phencyclidine on schedule-controlled behavior in the squirrel monkey.
    Chait LD; Balster RL
    J Pharmacol Exp Ther; 1978 Jan; 204(1):77-87. PubMed ID: 412949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum.
    Proksch JW; Gentry WB; Owens SM
    Drug Metab Dispos; 2000 Jul; 28(7):742-7. PubMed ID: 10859146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination.
    Beardsley PM; Balster RL; Salay JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):159-65. PubMed ID: 3572780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral dependence upon phencyclidine and ketamine in the rat.
    Beardsley PM; Balster RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):203-11. PubMed ID: 3612525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of phencyclidine and pentobarbital on fixed-interval performance in rhesus monkeys.
    Woolverton WL; Balster RL
    J Pharmacol Exp Ther; 1981 Jun; 217(3):611-8. PubMed ID: 7229995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol.
    Slifer BL; Balster RL
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):273-80. PubMed ID: 6545061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drugs on schedule-controlled behavior in rats during chronic haloperidol administration.
    Rastogi SK; McMillan DE
    J Pharmacol Exp Ther; 1985 Feb; 232(2):295-300. PubMed ID: 3968634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
    Owens SM; Gunnell M; Laurenzana EM; Valentine JL
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1261-6. PubMed ID: 8510006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    Valentine JL; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):717-24. PubMed ID: 8768723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
    Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
    Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to phencyclidine in pigeons: cross-tolerance to ketamine.
    Wenger GR
    J Pharmacol Exp Ther; 1983 Jun; 225(3):646-52. PubMed ID: 6864526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative assessment of phencyclidine dependence produced by oral self-administration in rhesus monkeys.
    Carroll ME
    J Pharmacol Exp Ther; 1987 Aug; 242(2):405-12. PubMed ID: 3612542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine.
    Beardsley PM; Balster RL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):34-40. PubMed ID: 3336008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.